Skip to main content
Home
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
      • Allergy & Asthma
      • Autoimmune Disease
      • Transplantation
      • Type 1 Diabetes
    • Core Facilities
    • Lab Protocols
      • ITN Protocols
      • T1D Preclinical Consortium
    • Policies
      • Publications Policy
    • Proposals
      • Submit Proposal
      • Current RFPs
      • Past RFPs
    • Publications
    • TrialShare
    • Strategic Plans
      • Allergy
      • Autoimmune Disease
        • Type 1 Diabetes
      • Transplantation
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
      • Kidney
      • Liver
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
      • BRI - Seattle Office
      • UCSF - San Francisco Office
    • Media Inquiries
Home

Secondary links

  • Home
  • TrialShare
  • Member Portal
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
    • Core Facilities
    • Lab Protocols
    • Policies
    • Proposals
    • Publications
    • TrialShare
    • Strategic Plans
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
    • Media Inquiries

Primary links

  • About Us
  • Mission & Values
  • Leadership
  • News
  • Careers
  • Partnerships
  • Support
  • Achievements

ITN Hosts “A View Towards (Immune) Tolerance” Symposium at FOCIS 2012

June 12, 2012 --

The Immune Tolerance Netowork (ITN) is hosting a Member Society Symposium entitled “A View Towards (Immune) Tolerance” on June 20th, 2012 at the Federation of Clinical Immunology Societies (FOCIS) annual meeting in Vancouver, BC, Canada.

The symposium highlights ITN’s recent clinical and mechanistic achievements in allergy, autoimmunity, and solid organ transplantation. The list of talks and speakers is below:

A View (Towards) Immune Tolerance
Wednesday, June 20th, 2012
8:00am-12:00pm

8:00 – 8:15

Introduction
Chairperson: Jerry Nepom MD, PhD, Immune Tolerance Network

8:15 – 9:00

Anti-CD3 in Type I Diabetes
Kevan Herold, MD, Yale University

9:00 – 9:45

IL-2 Therapy in Autoimmune Disease
Jane Buckner, MD, Benaroya Research Institute

9:45 – 10:30

TCR repertoire studies in ITN trial of autologous hematopoietic transplantation in MS
Paolo Muraro, MD, PhD, Imperial College London

10:30 – 11:15

The GRASS study: Novel local and cellular biomarkers for monitoring immunological changes following allergen-specific immunotherapy
Mohamed Shamji, PhD, Imperial College London

11:15 – 12:00

Diagnostic and Predictive Markers of Tolerance in Solid Organ Transplantation
Ken Newell, MD, PhD, Emory University

For more information about the symposium or the FOCIS meeting, visit www.focisnet.org

The Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

National Institute of Allergy and Infectious Diseases

Footer

  • Home
  • Sponsors
  • Careers
  • Contact
  • Search

© 2021 Immune Tolerance Network

  • Privacy
  • Terms of Use
  • Accessibility